| Basic data
|
| (21) | Request Number: | S20200007A (Supplementary Protection Certificate granted) |
| (22) | Request Date: | 21.05.2020 |
| (43) | Request Publication Date: | 12.06.2020 |
| |
| (71) | Applicant(s): | | 1. | AMGEN INC., One Amgen Center Drive, Thousand Oaks, CA 91320, US |
|
| (74) | Representative: | PETOŠEVIĆ d.o.o.,
Ulica Josipa Račića 2, 10000 Zagreb, HR
|
| |
| (68) | Basic Patent Number: | P20130803 |
| (21) | Application Number | P20130803A |
| (22) | Filing Date | 22.08.2013 |
| (54) | Title of Invention: | SCLEROSTIN BINDING AGENTS |
| |
| (95) | Product Name: | ROMOSOZUMAB |
| |
| (92)(93) | Number and Date of First Marketing Authorisation: | | EU/1/19/1411/001-004, 11.12.2019 |
|
| |
| (11) | SPC Number: | S20200007 |
| | Date of Grant: | 04.12.2023 |
| | Publication Date: | 22.12.2023 |
| (94) | Validity Period: | 29.04.2026 - 28.04.2031 |
| |
| |